MegaRobo secures $200 million for its laboratories

MegaRobo Technologies announces a fundraising of nearly $200 million to build laboratories where AI can conduct experiments. The Chinese company specializing in laboratory automation also plans international expansion.
Megalaxy Lab to Test Over 10,000 Proteins
With Poreva Open, a competition dedicated to protein design, MegaRobo has partnered with Tencent Cloud and Twist Bioscience, a DNA manufacturer. In this context, Megalaxy Lab will need to submit over 10,000 proteins conceived by AI to physical testing. The goal is to establish a shared reference based on experimental measurements. Anthropic, for its part, entrusted external laboratories in August with the verification of proteins designed by Claude.
Megalaxy Lab allows scientists and AI agents to send tests to robotic laboratories. MegaRobo claims that this service has already benefited more than 200 of its clients. The company boasts a total of over 500 clients, primarily among pharmaceutical manufacturers, biotechnology firms, and research laboratories.
Models Connected to Laboratory Instruments
Reading scientific publications or predicting molecules falls within the capabilities of AI; scientific validation still requires real testing. MegaRobo's device connects models to robots and instruments: a model can prepare an experiment, execute it, and then rely on the results to determine the next test. Daniel Huang, founder and CEO of MegaRobo, believes that AI can thus go beyond interpreting the world to help produce knowledge, materials, processes, and products.
Le brief IA que les pros lisent chaque soir
Les 7 actus IA du jour, décryptées en 5 min. Gratuit.
Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.
Choisissez votre rythme
Gratuit · Pas de spam · Désabonnement en 1 clic
The expansion envisioned by MegaRobo covers North America, Europe, the Middle East, and Asia. The company also plans to employ its technology outside the scientific domain.
MegaRobo Claims Approximately $600 Million Raised
The Oman Investment Authority, the sovereign wealth fund of Oman, is participating in the new funding, along with CMB International, which joins the investors. Asia Investment Capital, Granite Asia, and Sinovation Ventures, already involved, are also contributing. No valuation has been made public. MegaRobo estimates its total fundraising at around $600 million, including a $300 million operation backed by Goldman Sachs in 2022.
Other funding concerns AI-assisted drug design: Isomorphic Labs, an Alphabet company, secured $5 billion on Tuesday, while Chai Discovery raised $400 million in July. In Berlin, Dunia Innovations is building a robotic laboratory for €280 million aimed at testing AI-derived designs.
Brief IA — L'actualité IA en français
L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.